Patents by Inventor Philip Kestell

Philip Kestell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-cancer composition comprising DMXAA or related compound
    Patent number: 7585893
    Abstract: The present invention relates to the use of compounds such as compounds of the xanthenone acetic acid class such as 5,6-dimethylxanthenone-4-acetic acid (DMXAA) for the treatment of cancer, wherein the compounds are administered gastrointestinally, preferably orally. More particularly, the invention is concerned with the use of such compounds, wherein the compound is delivered to the site of action in the patient to be treated in two or more doses.
    Type: Grant
    Filed: April 28, 2005
    Date of Patent: September 8, 2009
    Assignee: Cancer Research Technology Limited
    Inventors: Bruce Charles Baguley, Lai-Ming Ching, Philip Kestell, Liangli Zhao
  • ANTI-CANCER COMBINATIONS
    Publication number: 20090062377
    Abstract: The present invention relates to synergistic combinations of the compounds of formula I such as compounds of the xanthenone acetic acid class such as 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and NSAIDs, in particular diclofenac, which have anti-tumour activity. More particularly, the invention is concerned with the use of such combinations in the treatment of cancer and pharmaceutical compositions containing said combinations.
    Type: Application
    Filed: November 3, 2008
    Publication date: March 5, 2009
    Inventors: Liang-Chuan Steve Wang, James William Paxton, Lai-Ming Ching, Bruce Charles Baguley, Philip Kestell
  • Anti-cancer combinations
    Patent number: 7462642
    Abstract: The present invention relates to synergistic combinations of the compounds of formula I such as compounds of the xanthenone acetic acid class such as 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and NSAIDs, in particular diclofenac, which have anti-tumor activity. More particularly, the invention is concerned with the use of such combinations in the treatment of cancer and pharmaceutical compositions containing said combinations.
    Type: Grant
    Filed: September 22, 2004
    Date of Patent: December 9, 2008
    Assignee: Cancer Research Technology Limited
    Inventors: Liang-Chuan Steve Wang, James William Paxton, Lai-Ming Ching, Bruce Charles Baguley, Philip Kestell
  • Anti cancer combinations comprising a cox-2 inhibitor
    Publication number: 20070082937
    Abstract: The present invention relates to synergistic combinations of the compounds of formula (I) such as compounds of the xanthenone acetic acid class such as 5,6dimethylxanthenone-4-acetic acid (DMXAA) and a selective COX-2 inhibitor, in particular rofecoxib, which have anti-tumour activity. More particularly, the invention is concerned with the use of such combinations in the treatment of cancer and pharmaceutical formulations containing said combinations.
    Type: Application
    Filed: September 2, 2004
    Publication date: April 12, 2007
    Applicant: Cancer Research Technology Limited
    Inventors: Bruce Baguley, James Paxton, Liang-Chuan Wang, Philip Kestell, Lai-Ming Ching
  • Anti-cancer composition comprising DMXAA or related compound
    Publication number: 20060009505
    Abstract: The present invention relates to the use of compounds such as compounds of the xanthenone acetic acid class such as 5,6-dimethylxanthenone-4-acetic acid (DMXAA) for the treatment of cancer, wherein the compounds are administered gastrointestinally, preferably orally. More particularly, the invention is concerned with the use of such compounds, wherein the compound is delivered to the site of action in the patient to be treated in two or more doses.
    Type: Application
    Filed: April 28, 2005
    Publication date: January 12, 2006
    Inventors: Bruce Baguley, Lai-Ming Ching, Philip Kestell, Liangli Zhao
  • Anti-cancer combinations
    Publication number: 20050131059
    Abstract: The present invention relates to synergistic combinations of the compounds of formula I such as compounds of the xanthenone acetic acid class such as 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and NSAIDs, in particular diclofenac, which have anti-tumour activity. More particularly, the invention is concerned with the use of such combinations in the treatment of cancer and pharmaceutical compositions containing said combinations.
    Type: Application
    Filed: September 22, 2004
    Publication date: June 16, 2005
    Inventors: Liang-Chuan Wang, James Paxton, Lai-Ming Ching, Bruce Baguley, Philip Kestell